Skip to main content

JG 8121 Pill: yellow, capsule/oblong, 22mm

Generic Name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide

The pill with imprint JG 8121 (Yellow, Capsule/Oblong, 22mm) has been identified as Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg and is used for HIV Infection. It belongs to the drug class antiviral combinations and is not a controlled substance.

Images for JG 8121

Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg JG 8121
Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg JG 8121

Symtuza

Generic Name
cobicistat/darunavir/emtricitabine/tenofovir alafenamide
Imprint
JG 8121
Strength
cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
Color
Yellow
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
59676-0800
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, magnesium silicate, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.